Author: Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
EPIDEMIOLOGIC STUDIES AND CLINICAL TRIALS IN CHRONIC DISEASES- PROCEEDINGS OF A SYMPOSIUM HELD DURING THE 11TH MEETING OF THE PAHO ADVISORY COMMITTEE ON MEDICAL RESEARCH.
Epidemiologic Studies and Clinical Trials in Chronic Diseases
Author: Epidemiologic Studies and Clinical Trials in Chronic Diseases
Author: EPIDEMIOLOGIC STUDIES AND CLINICAL TRIALS IN CHRONIC DISEASES: PROCEEDINGS OF A SYMPOSIUM HELD DURING THE ELEVENTH MEETING OF THE PAHO ADVISORY COMMITTEE ON MEDICAL RESEARCH, JUNE 20, 1972
Author: Pan American Sanitary BureauPublisher:
ISBN:
Category :
Languages : en
Pages : 100
Book Description
Behavioral Clinical Trials for Chronic Diseases
Author: Lynda H. PowellPublisher: Springer Nature
ISBN: 3030393305
Category : Psychology
Languages : en
Pages : 324
Book Description
This is the first comprehensive guide to the design of behavioral randomized clinical trials (RCT) for chronic diseases. It includes the scientific foundations for behavioral trial methods, problems that have been encountered in past behavioral trials, advances in design that have evolved, and promising trends and opportunities for the future. The value of this book lies in its potential to foster an ability to “speak the language of medicine” through the conduct of high-quality behavioral clinical trials that match the rigor commonly seen in double-blind drug trials. It is relevant for testing any treatment aimed at improving a behavioral, social, psychosocial, environmental, or policy-level risk factor for a chronic disease including, for example, obesity, sedentary behavior, adherence to treatment, psychosocial stress, food deserts, and fragmented care. Outcomes of interest are those that are of clinical significance in the treatment of chronic diseases, including standard risk factors such as cholesterol, blood pressure, and glucose, and clinical outcomes such as hospitalizations, functional limitations, excess morbidity, quality of life, and mortality. This link between behavior and chronic disease requires innovative clinical trial methods not only from the behavioral sciences but also from medicine, epidemiology, and biostatistics. This integration does not exist in any current book, or in any training program, in either the behavioral sciences or medicine.
Textbook of Clinical Epidemiology
Author: Chongjian WangPublisher: Springer Nature
ISBN: 9819936225
Category : Medical
Languages : en
Pages : 365
Book Description
This book is a comprehensive and practical introduction of clinical epidemiology for students and practitioners. It covers both the basic principles and concepts of clinical epidemiology as well as its applications in various medical disciplines. It covers how to design, conduct, and interpret clinical studies using methods such as bias analysis, confounding control, causality assessment, diagnosis evaluation, prognosis prediction treatment comparison, and meta-analysis in this book. It also introduces how to apply these skills to real-world scenarios through case studies and examples that provide a fresh perspective on familiar topics. This book is a useful textbook for graduate and undergraduate students in medical schools, including MBBS (Bachelor of Medicine and Bachelor of Surgery) student.
Epidemiology for Public Health Practice
Author: FriisPublisher: Jones & Bartlett Publishers
ISBN: 1449666639
Category : Education
Languages : en
Pages : 748
Book Description
5161-8
Epidemiology for Public Health Practice
Author: Robert H. FriisPublisher: Jones & Bartlett Learning
ISBN: 9780763731700
Category : Epidemiology
Languages : en
Pages : 642
Book Description
Now in its third edition, Epidemiology for Public Health Practice provides a comprehensive look at all major topics, from study designs and descriptive epidemiology to quantitative measures and termin
Applied Epidemiologic Principles and Concepts
Author: Laurens Holmes, Jr.Publisher: CRC Press
ISBN: 1315352753
Category : Medical
Languages : en
Pages : 324
Book Description
This book provides practical knowledge to clinicians and biomedical researchers using biological and biochemical specimen/samples in order to understand health and disease processes at cellular, clinical, and population levels. Concepts and techniques provided will help researchers design and conduct studies, then translate data from bench to clinics in attempt to improve the health of patients and populations. This book presents the extreme complexity of epidemiologic research in a concise manner that will address the issue of confounders, thus allowing for more valid inferences and yielding results that are more reliable and accurate.
Analysis of Cancer Risks in Populations Near Nuclear Facilities
Author: National Research CouncilPublisher: National Academies Press
ISBN: 0309255716
Category : Medical
Languages : en
Pages : 424
Book Description
In the late 1980s, the National Cancer Institute initiated an investigation of cancer risks in populations near 52 commercial nuclear power plants and 10 Department of Energy nuclear facilities (including research and nuclear weapons production facilities and one reprocessing plant) in the United States. The results of the NCI investigation were used a primary resource for communicating with the public about the cancer risks near the nuclear facilities. However, this study is now over 20 years old. The U.S. Nuclear Regulatory Commission requested that the National Academy of Sciences provide an updated assessment of cancer risks in populations near USNRC-licensed nuclear facilities that utilize or process uranium for the production of electricity. Analysis of Cancer Risks in Populations near Nuclear Facilities: Phase 1 focuses on identifying scientifically sound approaches for carrying out an assessment of cancer risks associated with living near a nuclear facility, judgments about the strengths and weaknesses of various statistical power, ability to assess potential confounding factors, possible biases, and required effort. The results from this Phase 1 study will be used to inform the design of cancer risk assessment, which will be carried out in Phase 2. This report is beneficial for the general public, communities near nuclear facilities, stakeholders, healthcare providers, policy makers, state and local officials, community leaders, and the media.